US Patent Issued to Bio-Thera Solutions on July 14 for "Recombinant antibody having unique glycan profile produced by CHO host cell with edited genome and preparation method thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,895, issued on July 14, was assigned to Bio-Thera Solutions Ltd. (Guangzhou, China).

"Recombinant antibody having unique glycan profile produced by CHO host cell with edited genome and preparation method thereof" was invented by Chao Qin (Guangzhou, China), Yuanqing Zhou (Guangzhou, China) and Cuizhen Xiao (Guangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention, in the field of bioengineering and biotechnology, relates to a method for preparing a recombinant antibody with a unique glycan profile produced by a genome-edited CHO host cell. Specifically, according to a method of the present invention, the TALEN technology...